AnGes, Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) (NCT04993586) | AnGes, Inc. | 2021-07-29 |
| Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) (NCT04655625) | AnGes, Inc. | 2020-11-23 |
| Study of COVID-19 DNA Vaccine (AG0302-COVID19) (NCT04527081) | AnGes, Inc. | 2020-08-31 |
| Study of COVID-19 DNA Vaccine (AG0301-COVID19) (NCT04463472) | AnGes, Inc. | 2020-06-29 |
| AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain (NCT03263611) | AnGes, Inc. | 2018-02-26 |
Track AnGes, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.